Alkermes plc revised earnings guidance for the fiscal year 2023. for the year, the company expects Net income according to generally accepted accounting principles in the U.S. (GAAP) is now expected to be in the range of $250 million to $280 million, revised from the prior expectation of $225 million to $265 million. GAAP earnings per share (diluted)+ are now expected to be in the range of $1.46 to $1.63, revised from the prior expectation of $1.31 to $1.54.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.06 USD | +2.80% | +0.15% | -13.28% |
05-23 | Cantor Fitzgerald Adjusts Alkermes Price Target to $48 From $43, Maintains Overweight Rating | MT |
05-02 | UBS Adjusts Price Target on Alkermes to $21 From $23, Maintains Sell Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.28% | 4.07B | |
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+38.85% | 39.03B | |
+14.28% | 26.75B | |
-11.17% | 26.86B | |
-21.40% | 19.03B | |
+25.64% | 12.26B | |
+0.96% | 12.28B | |
+27.04% | 12.04B |
- Stock Market
- Equities
- ALKS Stock
- News Alkermes plc
- Alkermes plc Revises Earnings Guidance for the Fiscal Year 2023